We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-13.9%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$8.16B
AUM Growth
+$248M
Cap. Flow
+$1.5B
Cap. Flow %
18.35%
Top 10 Hldgs %
14.12%
Holding
2,786
New
644
Increased
646
Reduced
549
Closed
902

Top Buys

Rank Stock Value
1
ETR icon
Entergy
ETR
+$79.1M
2
DTE icon
DTE Energy
DTE
+$73.2M
3
FDX icon
FedEx
FDX
+$48.6M
4
MPC icon
Marathon Petroleum
MPC
+$47.5M
5
CMS icon
CMS Energy
CMS
+$45.3M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$75.8M
2
XOM icon
ExxonMobil
XOM
+$62M
3
LIN icon
Linde
LIN
+$49.9M
4
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$38.6M
5
EXPE icon
Expedia Group
EXPE
+$29.7M

Sector Composition

Rank Sector Weight
1 Industrials 14.24%
2 Technology 13.54%
3 Utilities 9.55%
4 Financials 8.68%
5 Healthcare 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRE icon
2001
Costamare
CMRE
$1.89B
-77,087
Closed -$1.31M
CMTG icon
2002
Claros Mortgage Trust
CMTG
$253M
-204,960
Closed -$3.51M
CNS icon
2003
Cohen & Steers
CNS
$4.19B
-12,452
Closed -$1.07M
CNXC icon
2004
Concentrix
CNXC
$1.55B
-5,692
Closed -$948K
CODI icon
2005
Compass Diversified
CODI
$879M
-213,342
Closed -$5.07M
CODX
2006
Co-Diagnostics
CODX
$7.57M
-443
Closed -$82K
COHR icon
2007
PUT
Coherent
COHR
$56.7B
-125,000
Closed -$9.06M
COIN icon
2008
Coinbase
COIN
$49.2B
-12,671
Closed -$2.41M
COLM icon
2009
Columbia Sportswear
COLM
$3.09B
-16,162
Closed -$1.46M
VISN
2010
Vistance Networks Inc
VISN
$2.59B
-169,644
Closed -$1.34M
COMP icon
2011
Compass
COMP
$9.02B
-799,462
Closed -$6.28M
COST icon
2012
Costco
COST
$420B
-18,560
Closed -$10.7M
CRCT icon
2013
Cricut
CRCT
$1.17B
-30,532
Closed -$400K
CRDF icon
2014
Cardiff Oncology
CRDF
$68.5M
-18,164
Closed -$45K
CRVS icon
2015
Corvus Pharmaceuticals
CRVS
$1.22B
-25,563
Closed -$42K
CTKB icon
2016
Cytek Biosciences
CTKB
$625M
-27,049
Closed -$292K
CTRN icon
2017
Citi Trends
CTRN
$597M
-14,636
Closed -$448K
CTXR icon
2018
Citius Pharmaceuticals
CTXR
$16.5M
-1,220
Closed -$55K
CVLT icon
2019
Commault Systems
CVLT
$5.55B
-3,179
Closed -$211K
CVM icon
2020
CEL-SCI Corp
CVM
$25M
-335
Closed -$40K
CVX icon
2021
Chevron
CVX
$403B
-2,474
Closed -$403K
CW icon
2022
Curtiss-Wright
CW
$23.5B
-2,174
Closed -$326K
CWBC
2023
Community West Bancshares
CWBC
$703M
-9,138
Closed -$213K
CWT icon
2024
California Water Service
CWT
$3.06B
-26,965
Closed -$1.6M
CXM icon
2025
CALL
Sprinklr
CXM
$1.73B
-250,000
Closed -$2.98M

Similar funds

Michael Gelband's Q2 2022 Portfolio in Review

As of Q2 2022, Michael Gelband held 2,786 positions worth $8.16B, up 3.1% from $7.91B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Michael Gelband deployed $1.5B of net new capital in Q2 2022, opening 644 new positions and adding to 646 existing holdings. Its largest new stake was Marathon Petroleum: 508,082 shares worth $41.8M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Utilities.

On the sell side, the largest reduction was AT&T, an estimated $75.8M trimmed.

  • Michael Gelband's largest Q2 2022 buy was Marathon Petroleum: 508,082 shares worth $41.8M.
  • Michael Gelband added most to Entergy in Q2 2022, an estimated $79.1M increase.
  • Michael Gelband's biggest Q2 2022 reduction was AT&T, cutting an estimated $75.8M.
  • Michael Gelband fully exited Linde in Q2 2022, selling an estimated $49.9M.
  • Michael Gelband's ten largest holdings make up 14% of its $8.16B portfolio in Q2 2022.
  • Michael Gelband opened 644 new positions and closed 902 in Q2 2022.
  • Michael Gelband's portfolio value rose 3.1% quarter-over-quarter to $8.16B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.